Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
28.91
-1.37 (-4.52%)
Mar 6, 2026, 4:00 PM EST - Market closed
Forte Biosciences Employees
Forte Biosciences had 14 employees as of December 31, 2024. The number of employees increased by 5 or 55.56% compared to the previous year.
Employees
14
Change (1Y)
5
Growth (1Y)
55.56%
Revenue / Employee
n/a
Profits / Employee
-$3,233,875
Market Cap
515.51M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Allogene Therapeutics | 229 |
| uniQure | 209 |
| Rocket Pharmaceuticals | 202 |
| Alpha Tau Medical | 125 |
| Neumora Therapeutics | 95 |
| CorMedix | 65 |
| Larimar Therapeutics | 65 |
| Lexeo Therapeutics | 61 |
FBRX News
- 2 days ago - Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules - Business Wire
- 25 days ago - Forte Biosciences, Inc. to Present at Upcoming Investor Meetings - Business Wire
- 2 months ago - Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - Business Wire
- 4 months ago - Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update - Business Wire
- 4 months ago - Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences - Business Wire
- 5 months ago - Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - Business Wire
- 6 months ago - Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium - Business Wire
- 7 months ago - Forte Biosciences, Inc. Announces Results and Provides Update - Business Wire